DMAC Stock Earnings: DiaMedica Therapeutics Meets EPS for Q4 2023

DiaMedica Therapeutics (NASDAQ:DMAC) just reported results for the fourth quarter of 2023.DiaMedica Therapeutics reported earnings per share of -14 cents. This met the analyst estimate for EPS of -14 cents.The company did not report any revenue for the quarter.InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to a ...